Indici bursieri Piețe bursiere Simboluri Statistici

Simbol NTLA
Intellia Therapeutics Inc.

duminică, 14 aprilie 2024, ora 11:29:39 EEST (UTC + 3)

Simbol NTLA
Simbol NTLA
Simbol eToro NTLA
MarketWatch NTLA
Finviz NTLA
Yahoo Finance NTLA
Google Finance NTLA
TradingView NTLA
Denumire Intellia Therapeutics Inc.
Website intelliatx.com
Piața NASDAQ
ISIN US45826J1051
Sector Health Technology
Industrie Biotechnology
Monedă USD
Preț 45,6800 USD
Capitalizare bursieră 4,030 mld. USD
P/E -8,49
Beta 2,1347
EPS -5,3879
Profit anual -27,80%
Dată actualizare 12.07.2023


Descriere
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.


Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
21.10.2021 0,00 1,6128 9,490 0,00% -2,8592 +464,30% $0,00
12.07.2023 -8,49 2,1347 4,030 0,00% -5,3879 -27,80% $45,68



Pagină vizualizată de 60 ori și generată în 0,023077 secunde.